Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation study. - Chen JJ; Jin ZC; Zhou JW; Ding R; Tie J; Xin YJ; Zhang L; Huang M; Zhu XL; Zhou GH; Ji F; Zhu KS; et al. (EClinicalMedicine, 2026)